The result suggested that SEPT6_TRIM33 fusion gene [hazard ratio (HR): 242.69, P=0.046] and mutated TP53 pathway (HR: 14.06, P=0.03) were independent prognostic factors for B-cell lymphoma patients (Figure 5). Here, TP53 is linked to B-cell non-Hodgkin lymphoma.